Study sheds a light on the cause of endocrine autoimmune diseases (IRAEs) that occur in about 20% of patients treated with checkpoint immunotherapy.
Wonderful collaborating with Dr. Maureen Su and so many others at UCLA and USC.
Just published in Science Translational Medicine:
Comentários